Sort
85,873 grants matching “alzheimers”
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$814,164John Hsu · Massachusetts General Hospital · U01 · FY2024 · AG
High throughput tau oligomer drug screening assay for Alzheimer's disease
$814,009James G. Moe · Oligomerix, Inc · R44 · FY2014 · AG
Modulation effects of Baduanjin mind-body exercise on subjective cognitive decline
$813,924Jian Kong · Massachusetts General Hospital · R01 · FY2019 · AG
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
$813,845Matcheri S. Keshavan · Wayne State University · R01 · FY2008 · MH
Linking dementia pathology and alteration in brain activation to complex daily functional decline during the preclinical dementia stage
$813,807Pierfilippo De Sanctis · Albert Einstein College Of Medicine · R01 · FY2024 · AG
Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in Elderly with Alzheimer's Disease Study (D-PRESCRIBE-AD)
$813,790Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R61 · FY2020 · AG
Predictors of Severity in Alzheimer's Disease
$813,764Yaakov Stern · Columbia University Health Sciences · R01 · FY2008 · AG
Tau progression index (TPI): An individualized predictor of Alzheimer's Disease trajectory based on subject-specific connectomes
$813,701Qolamreza Ray Razlighi · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG
Metabolic and Hormonal Mechanisms of VCID
$813,675Kristen Leanne Zuloaga · Albany Medical College · R01 · FY2025 · NS
A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials
$813,603Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · AG
Molecular mechanism of bidirectional transport
$813,592William Olaf Hancock · Pennsylvania State University, The · R35 · FY2023 · GM
Neural substrates of diffusion imaging in cognitively aging rhesus monkeys
$813,477Marek Kubicki · Brigham And Women'S Hospital · R01 · FY2023 · AG
Clinical Core
$813,463Sandra Weintraub · Northwestern University At Chicago · P30 · FY2023 · AG
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
$813,443Mara A. McAdams Demarco · New York University School Of Medicine · R01 · FY2024 · AG
Cognitive and Physical Exercise to Improve Outcomes after Surgery in the Elderly
$813,435Christopher Hughes · Vanderbilt University Medical Center · R01 · FY2023 · AG
Alzheimer Disease Genetic Architecture in African Americans
$813,421Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2020 · AG
BRAIN IMAGING &COGNITION IN SUBJECTS AT RISK FOR AD
$813,372Johns Hopkins University · R01 · FY2003 · AG
Role of a novel risk loci HAVCR2 of late-onset Alzheimer's disease in the regulation of microglial response in neurodegeneration
$813,314Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2025 · AG
Single molecule studies of protein binding and aggregation
$813,248Hoi Sung Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimerâs disease
$813,171Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2019 · AG
Brain Vulnerability in Delirium and Alzheimerâs Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation
$813,127Sarinnapha Vasunilashorn · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG
Neuroinflammation, Perineural Nets, and Postoperative Delirium
$813,123Shiqian Shen · Massachusetts General Hospital · R01 · FY2024 · AG
Computational Tools for Research in Neuroscience, Behavioral Science and Mental H
$813,115I George Zubal · Molecular Neuroimaging, Llc · R42 · FY2014 · NS
Computational Tools for Research in Neuroscience, Behavioral Science and Mental H
$813,115I George Zubal · Molecular Neuroimaging, Llc · R42 · FY2013 · NS
Modulation effects of Baduanjin mind-body exercise on subjective cognitive decline
$813,069Jian Kong · Massachusetts General Hospital · R01 · FY2022 · AG